RUBY trial

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

October, 2024

RUBY trial

Aug 20, 2024, 14:50 | Drugs

Key takeaways from the FDA approval of dostarlimab-gxly in endometrial cancer - The Babak Lab

The Babak Lab shared on LinkedIn: "FDA Expands Endometrial Cancer Treatment: The FDA has approved…

Jun 12, 2024, 15:34 | Insight

Piotr Wysocki: Dostarlimab combined with chemotherapy in dMMR/MSI-H advanced endometrial cancer patietns

Piotr Wysocki recently posted on LinkedIn: "Part 1 of the RUBY trial (NCT03981796) evaluated the…

May 15, 2024, 04:12 | Blog

Tanja Obradovic: News about effectiveness of PD-1 inhibitors in endometrial cancer continues to paint complex picture

Tanja Obradovic shared on LinkedIn: ''News about effectiveness of PD-1 inhibitors in endometrial cancer continues…

All: 3 Posts: 1 - 100

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Lyda Hill Philanthropies Was Honored with the American Cancer Society Philanthropist of the Year Award

Why President Biden Values Cancer Research So Much: The Story Behind Cancer Moonshot

The 2024 NIH Director’s Awards

Tedros Adhanom Ghebreyesus Received 2024 Rebranding Africa Forum Governance Leadership Award

Special Coverage

ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023